Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Quantitation of 8-hydroxydeoxyguanosine in DNA by liquid chromatography/positive atmospheric pressure photoionization tandem mass spectrometry.

Zhang F, Stott WT, Clark AJ, Schisler MR, Grundy JJ, Gollapudi BB, Bartels MJ.

Rapid Commun Mass Spectrom. 2007;21(24):3949-55.

PMID:
17990277
2.

Effect of diisopropanolamine upon choline uptake and phospholipid synthesis in Chinese hamster ovary cells.

Stott WT, Kleinert KM.

Food Chem Toxicol. 2008 Feb;46(2):761-6. Epub 2007 Oct 6.

PMID:
17988777
3.

Repeated dose toxicity and developmental toxicity of diisopropanolamine to rats.

Johnson KA, Dryzga MD, Brooks KJ, Carney EW, Tornesi B, Stott WT.

Food Chem Toxicol. 2007 Oct;45(10):1838-45. Epub 2007 Apr 11.

PMID:
17507134
4.

Report of an ISRTP workshop: progress and barriers to incorporating alternative toxicological methods in the U.S.

Becker RA, Borgert CJ, Webb S, Ansell J, Amundson S, Portier CJ, Goldberg A, Bruner LH, Rowan A, Curren RD, Stott WT.

Regul Toxicol Pharmacol. 2006 Oct;46(1):18-22. Epub 2006 Jul 28.

PMID:
16876299
5.

Gene expression dose-response of liver with a genotoxic and nongenotoxic carcinogen.

Seidel SD, Stott WT, Kan HL, Sparrow BR, Gollapudi BB.

Int J Toxicol. 2006 Jan-Feb;25(1):57-64.

PMID:
16510358
6.

Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.

Leung HW, Kamendulis LM, Stott WT.

Regul Toxicol Pharmacol. 2005 Dec;43(3):260-71. Epub 2005 Sep 26. Review.

PMID:
16188361
7.

Investigation of the formation of N-nitrosodiethanolamine in B6C3F1 mice following topical administration of triethanolamine.

Saghir SA, Brzak KA, Markham DA, Bartels MJ, Stott WT.

Regul Toxicol Pharmacol. 2005 Oct;43(1):10-8.

PMID:
15905009
8.

Effect of strain and diet upon constitutive and chemically induced activities of several xenobiotic-metabolizing enzymes in rats.

Stott WT, Kan HL, McFadden LG, Sparrow BR, Gollapudi BB.

Regul Toxicol Pharmacol. 2004 Jun;39(3):325-33.

PMID:
15135211
9.

Profiles of gene expression changes in L5178Y mouse lymphoma cells treated with methyl methanesulfonate and sodium chloride.

Seidel SD, Sparrow BR, Kan HL, Stott WT, Schisler MR, Linscombe VA, Gollapudi BB.

Mutagenesis. 2004 May;19(3):195-201.

PMID:
15123784
10.

Evaluation of the potential of triethanolamine to alter hepatic choline levels in female B6C3F1 mice.

Stott WT, Radtke BJ, Linscombe VA, Mar MH, Zeisel SH.

Toxicol Sci. 2004 Jun;79(2):242-7. Epub 2004 Mar 31.

11.
12.

Mammalian toxicity of 1,3-dichloropropene.

Stott WT, Gollapudi BB, Rao KS.

Rev Environ Contam Toxicol. 2001;168:1-42. Review.

PMID:
12882226
13.

Identification of transcriptome profiles for the DNA-damaging agents bleomycin and hydrogen peroxide in L5178Y mouse lymphoma cells.

Seidel SD, Kan HL, Stott WT, Schisler MR, Gollapudi BB.

Environ Mol Mutagen. 2003;42(1):19-25.

PMID:
12874809
14.

Evaluation of potential modes of action of inhaled ethylbenzene in rats and mice.

Stott WT, Johnson KA, Bahnemann R, Day SJ, McGuirk RJ.

Toxicol Sci. 2003 Jan;71(1):53-66.

PMID:
12520075
15.

Propylene glycol monomethyl ether (PGME): inhalation toxicity and carcinogenicity in Fischer 344 rats and B6C3F1 mice.

Spencer PJ, Crissman JW, Stott WT, Corley RA, Cieszlak FS, Schumann AM, Hardisty JF.

Toxicol Pathol. 2002 Sep-Oct;30(5):570-9.

PMID:
12371666
16.

The pharmacokinetics of diethanolamine in Sprague-Dawley rats following intravenous administration.

Mendrala AL, Waechter JM Jr, Bormett GA, Bartels MJ, Stott WT.

Food Chem Toxicol. 2001 Sep;39(9):931-9.

PMID:
11498270
17.

Mechanistic aspects of the metabolism of 1,3-dichloropropene in rats and mice.

Bartels MJ, Brzak KA, Mendrala AL, Stott WT.

Chem Res Toxicol. 2000 Nov;13(11):1096-102.

PMID:
11087431
18.

Absorption, distribution, metabolism and excretion of intravenously and dermally administered triethanolamine in mice.

Stott WT, Waechter JM, Rick DL, Mendrala AL.

Food Chem Toxicol. 2000 Nov;38(11):1043-51.

PMID:
11038241
19.

Chronic toxicity and oncogenicity studies of ingested 1, 3-dichloropropene in rats and mice.

Stebbins KE, Johnson KA, Jeffries TK, Redmond JM, Haut KT, Shabrang SN, Stott WT.

Regul Toxicol Pharmacol. 2000 Aug;32(1):1-13.

PMID:
11029263
20.

Potential mechanisms of tumorigenic action of diethanolamine in mice.

Stott WT, Bartels MJ, Brzak KA, Mar M, Markham DA, Thornton CM, Zeisel SH.

Toxicol Lett. 2000 Apr 3;114(1-3):67-75.

PMID:
10713470
21.

Subchronic and chronic toxicity of ingested 1,3-dichloropropene in dogs.

Stebbins KE, Quast JF, Haut KT, Stott WT.

Regul Toxicol Pharmacol. 1999 Dec;30(3):233-43.

PMID:
10620473
22.

Mode of action considerations in the use of transgenic animals for mutagenicity and carcinogenicity evaluations.

Gollapudi BB, Stott WT, Yano BL, Bus JS.

Toxicol Lett. 1998 Dec 28;102-103:479-84.

PMID:
10022299
23.

Hepatic lacI and cII mutation in transgenic (lambdaLIZ) rats treated with dimethylnitrosamine.

Gollapudi BB, Jackson KM, Stott WT.

Mutat Res. 1998 Nov 9;419(1-3):131-5.

PMID:
9804924
24.

Bioavailability and pharmacokinetics of microencapsulated 1,3-dichloropropene in rats.

Stott WT, Gilbert JR, McGuirk RJ, Brzak KA, Alexander LM, Dryzga MD, Mendrala AL, Bartels MJ.

Toxicol Sci. 1998 Jan;41(1):21-8.

PMID:
9520338
25.

Evaluation of a novel assay of potential toxicity/neurotoxicity of carpet emissions (VOCs) in mice.

Stott WT, Beekman MJ, Johnson KA, Spencer PJ.

Food Chem Toxicol. 1997 Feb;35(2):241-54.

PMID:
9146737
26.

Toxicology of mono-, di-, and triethanolamine.

Knaak JB, Leung HW, Stott WT, Busch J, Bilsky J.

Rev Environ Contam Toxicol. 1997;149:1-86. Review.

PMID:
8956558
27.

Regulatory implications of peroxisome proliferation: an industrial perspective.

Stott WT.

Ann N Y Acad Sci. 1996 Dec 27;804:641-8. No abstract available.

PMID:
8993579
28.

Chronic dietary toxicity/oncogenicity studies on 2,4-dichlorophenoxyacetic acid in rodents.

Charles JM, Bond DM, Jeffries TK, Yano BL, Stott WT, Johnson KA, Cunny HC, Wilson RD, Bus JS.

Fundam Appl Toxicol. 1996 Oct;33(2):166-72.

PMID:
8921335
29.

Subchronic toxicity of ingested 1,3-dichloropropene in rats and mice.

Haut KT, Stebbins KE, Johnson KA, Shabrang SN, Stott WT.

Fundam Appl Toxicol. 1996 Aug;32(2):224-32.

PMID:
8921325
30.

Species-dependent induction of peroxisome proliferation by haloxyfop, an aryloxyphenoxy herbicide.

Stott WT, Yano BL, Williams DM, Barnard SD, Hannah MA, Cieszlak FS, Herman JR.

Fundam Appl Toxicol. 1995 Nov;28(1):71-9.

PMID:
8566486
31.

Biological monitoring of dichloropropene: air concentrations, urinary metabolite, and renal enzyme excretion.

Stott WT, Waechter JM, Quast JT.

Arch Environ Health. 1990 Jul-Aug;45(4):250-5. No abstract available.

PMID:
2400248
32.

Chronic toxicity and oncogenicity of picloram in Fischer 344 rats.

Stott WT, Johnson KA, Landry TD, Gorzinski SJ, Cieszlak FS.

J Toxicol Environ Health. 1990 Jun;30(2):91-104.

PMID:
2355403
33.

The chronic toxicity and oncogenicity of inhaled technical-grade 1,3-dichloropropene in rats and mice.

Lomax LG, Stott WT, Johnson KA, Calhoun LL, Yano BL, Quast JF.

Fundam Appl Toxicol. 1989 Apr;12(3):418-31.

PMID:
2731657
34.

Subchronic toxicity of inhaled technical grade 1,3-dichloropropene in rats and mice.

Stott WT, Young JT, Calhoun LL, Battjes JE.

Fundam Appl Toxicol. 1988 Aug;11(2):207-20.

PMID:
3220200
35.

Chemically induced proliferation of peroxisomes: implications for risk assessment.

Stott WT.

Regul Toxicol Pharmacol. 1988 Jun;8(2):125-59. Review.

PMID:
3051140
36.

Inhalation pharmacokinetics of technical grade 1,3-dichloropropene in rats.

Stott WT, Kastl PE.

Toxicol Appl Pharmacol. 1986 Sep 30;85(3):332-41.

PMID:
3764918
37.
38.
39.

Blood-flow distribution in the mouse.

Stott WT, Dryzga MD, Ramsey JC.

J Appl Toxicol. 1983 Dec;3(6):310-2.

PMID:
6677653
40.

The pharmacokinetics and macromolecular interactions of trichloroethylene in mice and rats.

Stott WT, Quast JF, Watanabe PG.

Toxicol Appl Pharmacol. 1982 Jan;62(1):137-51. No abstract available.

PMID:
7064149
41.

Nonlinear pharmacokinetics and their impact on toxicology: illustrated with dioxane.

Dietz FK, Stott WT, Ramsey JC.

Drug Metab Rev. 1982;13(6):963-81. Review. No abstract available.

PMID:
6754319
42.

Differentiation of genetic versus epigenetic mechanisms of toxicity and its application to risk assessment.

Stott WT, Watanabe PG.

Drug Metab Rev. 1982;13(5):853-73. Review. No abstract available.

PMID:
6754312
43.
44.

Genetic and nongenetic events in neoplasia.

Stott WT, Reitz RH, Schumann AM, Watanabe PG.

Food Cosmet Toxicol. 1981 Oct;19(5):567-76. Review. No abstract available.

PMID:
7030886
45.

Differentiation of the mechanisms of oncogenicity of 1,4-dioxane and 1,3-hexachlorobutadiene in the rat.

Stott WT, Quast JF, Watanabe PG.

Toxicol Appl Pharmacol. 1981 Sep 15;60(2):287-300. No abstract available.

PMID:
7281189
46.

Kinetic interaction of chemical mutagens with mouse sperm in vivo as it relates to animal mutagenic effects.

Stott WT, Watanabe PG.

Toxicol Appl Pharmacol. 1980 Sep 30;55(3):411-6. No abstract available.

PMID:
7434354
47.

Dietary protein levels and aflatoxin B metabolism in rainbow trout (Salmo gairdneri).

Stott WT, Sinnhuber RO.

J Environ Pathol Toxicol. 1978 Nov-Dec;2(2):379-88.

PMID:
739217
48.

Trout hepatic enzyme activation of aflatoxin B1 in a mutagen assay system and the inhibitory effect of PCBs1.

Stott WT, Sinnhuber RO.

Bull Environ Contam Toxicol. 1978 Jan;19(1):35-41.

PMID:
415776
49.
50.

Microbiological assay of patulin, using Bacillus megaterium.

Stott WT, Bullerman LB.

J Assoc Off Anal Chem. 1975 May;58(3):497-9.

PMID:
806575

Supplemental Content

Loading ...
Support Center